It helps control blood sugar levels and lowers risks related to heart problems
The exclusion criteria were: females who were pregnant or experiencing a menstrual period, type 2 diabetes treated using an insulin regimen, malignancy, hematopathy, active tuberculosis, peptic ulcer with gastric bleeding, binge-eating disorder, psychiatric disease, congestive heart failure, clinically relevant renal or hepatic insufficiency, unstable coronary artery disease, cancer or a history of cancer
Enhances production of GLP-1 (glucagon-like peptide-1), a hormone that regulates appetite, blood sugar levels, and insulin sensitivity
Es ist verschreibungspflichtig und darf bei Erwachsenen mit einem BMI ab 30 kg/m oder ab 27 kg/m mit gewichtsbedingten Begleiterkrankungen eingesetzt werden, wenn Lebensstilmanahmen allein nicht ausreichen
19 DPP4 inhibitors have gained recognition as oral anti-diabetic medications for the treatment of type 2 diabetes